简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-05-30 10:52 US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection
2025-05-29 12:21 BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology
2025-05-29 11:21 Cargill Earns #1 Global Ranking for Removing Trans Fats From Edible Oils Portfolio
2025-05-29 11:15 Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor
2025-05-28 15:58 Ghana’s Naomi Oyoe Ohene Oti Wins Aster Guardians Global Nursing Award 2025 Worth USD 250,000
2025-05-28 13:27 Galderma Buys Back Shares Worth CHF 233 Million in the Context of Accelerated Bookbuild Offering
2025-05-28 11:08 Quadria Capital Closes Oversubscribed US$1 Billion Fund III to Advance Healthcare Transformation Across Asia
2025-05-28 10:53 Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba
2025-05-28 10:50 New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration
2025-05-28 09:53 Takeda and Nature Announce Call for Applications Now Open for 2026 Innovators in Science Award
2025-05-27 16:05 World-Leading Cancer Center, The Royal Marsden NHS Foundation Trust, Using AI to Push Boundaries of Cancer Research With NTT DATA and CARPL.ai
2025-05-27 12:55 Revolutionizing Healthcare: Ubitus and MacKay Memorial Hospital Present AI Robot Collaboration at GTC Taiwan
2025-05-26 13:02 BeiGene Presents Pioneering Cancer Research at ASCO 2025 – Redefining Treatment Across Hematology and Solid Tumors
2025-05-23 13:05 Rubedo Life Sciences Announces First Patient Dosed with Lead Drug Candidate RLS-1496, the First GPX4 Modulator Targeting Pathologic Senescent Cells To Enter Phase 1 Clinical Trial
2025-05-23 12:52 Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
2025-05-22 11:51 CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 2025
2025-05-22 11:06 Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active Lupus Rash
2025-05-22 10:53 CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
2025-05-22 10:34 Novotech Honored with Triple Win in 2025 Pharmaceutical Technology Excellence Awards
2025-05-19 10:46 Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

Business Wire Weibo

Press Releases

Latest Releases